Racepinephrine Inhalation Solution, Usp 2.25%

Racepinephrine Inhalation Solution, Usp 2.25%
SPL v12
SPL
SPL Set ID dd1b35c7-b23b-4b95-8162-df3d263fe32e
Route
RESPIRATORY (INHALATION)
Published
Effective Date 2015-01-30
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Racepinephrine (11.25 mg)
Inactive Ingredients
Ascorbic Acid Citric Acid Monohydrate Edetate Disodium Water

Identifiers & Packaging

Marketing Status
OTC MONOGRAPH DRUG Active Since 2000-01-01

Description

Drug Facts

Purpose

Bronchodilator


Medication Information

Purpose

Bronchodilator

Description

Drug Facts

Uses

For temporary relief of mild symptoms of intermittent asthma:

  • Wheezing
  • Tightness of chest
  • Shortness of breath
Section 42229-5

Drug Facts

Section 50565-1
  • Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Section 50566-9

Stop use and ask a doctor if:

  • Your asthma is getting worse (See Asthma alert)
  • You have difficulty sleeping
  • You have a rapid heartbeat
  • You have tremors, nervousness, or seizure
Section 50567-7

When using this product:

Your blood pressure or heart rate may go up. This could increase your risk of heart attack or stroke, which may cause death.

  • Your risk of heart attack or stroke increases if you:
    • Have a history of high blood pressure or heart disease
    • Take this product more frequently or take more than the recommended dose.
    • Avoid foods or beverages that contain caffeine
    • Avoid dietary supplements containing ingredients reported or claimed to have a stimulant effect.
Section 50568-5

Ask a doctor or pharmacist before use if you are:

  • Taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions.
  • Taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain).
Section 50569-3

Ask a doctor before use if you have:

  • Ever been hospitalized for asthma
  • Heart disease
  • High blood pressure
  • Diabetes
  • Thyroid disease
  • Seizures
  • Narrow angle glaucoma
  • A psychiatric or emotional condition
  • Trouble urinating due to an enlarged prostate gland
Section 50570-1

Do not use:

  • Unless a doctor said you have asthma
  • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before taking this product.
  • If product is brown in color or cloudy
  • If its color is pinkish or darker than slightly yellow or if it contains a precipitate.
Section 53414-9
  • If pregnant or breast-feeding, ask a health professional before use.
Warnings

Warnings

Directions
  • The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine.
  • Do not use more than directed
  • For use in a hand-held rubber bulb nebulizer:

    Add 0.5 ml (contents of one vial) of solution to nebulizer.
  • Adults and children 4 years of age and over:

    1 to 3 inhalations not more often than every 3 hours.

    Do not use more than 12 inhalations in 24 hours.

    The use of this product by children should be supervised by an adult.
  • Children under 4 years of age: ask a doctor.
Questions?

1-800-443-4313

Monday through Friday, 8:00 a.m. to 5:00 p.m. (Eastern Standard Time).

Asthma Alert

Because asthma may be life threatening, see a doctor if you:

  • Are not better in 20 minutes
  • Get worse
  • Need more than 12 inhalations in 24 hours
  • Use more than 9 inhalations in 24 hours for 3 or more days a week
  • Have more than 2 asthma attacks in a week

These may be signs that your asthma is getting worse.

Other Information
  • Protect from light. Avoid excessive heat. Protect from freezing.
  • Store between 2°C and 25°C (36°F and 77°F).
  • How Supplied: S 2 ® Racepinephrine Inhalation Solution, USP 2.25% is supplied in 0.5 ml sterile unit-of-use vials.



    NDC 0487-5901-99 30 vials, each vial in an individual foil pouch.
Inactive Ingredients

Ascorbic acid, citric acid, edetate disodium, water for injection.

Active Ingredient (in Each 0.5 Ml)

Racepinephrine, USP 11.25 mg (as 13.5 mg of Racepinephrine HCl, USP).

Package Label, Principal Display Panel

Principle Display - Pouch Label (Individually Wrapped Vial)

NDC 0487-5901-99

Principle Display - Carton (30 Individually Wrapped Vials)

NDC 0487-5901-99


Structured Label Content

Uses

For temporary relief of mild symptoms of intermittent asthma:

  • Wheezing
  • Tightness of chest
  • Shortness of breath
Section 42229-5 (42229-5)

Drug Facts

Section 50565-1 (50565-1)
  • Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Section 50566-9 (50566-9)

Stop use and ask a doctor if:

  • Your asthma is getting worse (See Asthma alert)
  • You have difficulty sleeping
  • You have a rapid heartbeat
  • You have tremors, nervousness, or seizure
Section 50567-7 (50567-7)

When using this product:

Your blood pressure or heart rate may go up. This could increase your risk of heart attack or stroke, which may cause death.

  • Your risk of heart attack or stroke increases if you:
    • Have a history of high blood pressure or heart disease
    • Take this product more frequently or take more than the recommended dose.
    • Avoid foods or beverages that contain caffeine
    • Avoid dietary supplements containing ingredients reported or claimed to have a stimulant effect.
Section 50568-5 (50568-5)

Ask a doctor or pharmacist before use if you are:

  • Taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions.
  • Taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain).
Section 50569-3 (50569-3)

Ask a doctor before use if you have:

  • Ever been hospitalized for asthma
  • Heart disease
  • High blood pressure
  • Diabetes
  • Thyroid disease
  • Seizures
  • Narrow angle glaucoma
  • A psychiatric or emotional condition
  • Trouble urinating due to an enlarged prostate gland
Section 50570-1 (50570-1)

Do not use:

  • Unless a doctor said you have asthma
  • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before taking this product.
  • If product is brown in color or cloudy
  • If its color is pinkish or darker than slightly yellow or if it contains a precipitate.
Section 53414-9 (53414-9)
  • If pregnant or breast-feeding, ask a health professional before use.
Purpose

Bronchodilator

Warnings

Warnings

Directions
  • The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine.
  • Do not use more than directed
  • For use in a hand-held rubber bulb nebulizer:

    Add 0.5 ml (contents of one vial) of solution to nebulizer.
  • Adults and children 4 years of age and over:

    1 to 3 inhalations not more often than every 3 hours.

    Do not use more than 12 inhalations in 24 hours.

    The use of this product by children should be supervised by an adult.
  • Children under 4 years of age: ask a doctor.
Questions?

1-800-443-4313

Monday through Friday, 8:00 a.m. to 5:00 p.m. (Eastern Standard Time).

Asthma Alert (Asthma alert)

Because asthma may be life threatening, see a doctor if you:

  • Are not better in 20 minutes
  • Get worse
  • Need more than 12 inhalations in 24 hours
  • Use more than 9 inhalations in 24 hours for 3 or more days a week
  • Have more than 2 asthma attacks in a week

These may be signs that your asthma is getting worse.

Other Information
  • Protect from light. Avoid excessive heat. Protect from freezing.
  • Store between 2°C and 25°C (36°F and 77°F).
  • How Supplied: S 2 ® Racepinephrine Inhalation Solution, USP 2.25% is supplied in 0.5 ml sterile unit-of-use vials.



    NDC 0487-5901-99 30 vials, each vial in an individual foil pouch.
Inactive Ingredients

Ascorbic acid, citric acid, edetate disodium, water for injection.

Active Ingredient (in Each 0.5 Ml) (Active ingredient (in each 0.5 ml))

Racepinephrine, USP 11.25 mg (as 13.5 mg of Racepinephrine HCl, USP).

Package Label, Principal Display Panel (PACKAGE LABEL, PRINCIPAL DISPLAY PANEL)

Principle Display - Pouch Label (Individually Wrapped Vial)

NDC 0487-5901-99

Principle Display - Carton (30 Individually Wrapped Vials)

NDC 0487-5901-99


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)